Related Experiment Video

Updated: Feb 13, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.2K

The Effect of Hajj Pilgrimage on Treatment Compliance in Individuals with Chronic Diseases

Feride Taskin Yilmaz1, Selma Sabanciogullari2, Gulseren Karabey3

  • 1Department of Internal Diseases Nursing, School of Susehri Health High, Cumhuriyet University, 58140, Sivas, Turkey. feride_taskin@hotmail.com.

Journal of Religion and Health
|March 16, 2018
PubMed

Insights

Hajj pilgrimage negatively impacts short-term treatment compliance for chronic disease patients. Long-term compliance remained unchanged, with no link found between religiousness and disease complaint changes.

Area of Science:

  • Medical Sociology
  • Public Health
  • Religious Studies

Background:

  • Chronic diseases require consistent treatment adherence for effective management.
  • The Hajj pilgrimage is a significant religious obligation involving substantial physical and psychological demands.
  • Understanding the impact of major life events on health behaviors is crucial.

Purpose of the Study:

  • To investigate the effect of Hajj pilgrimage on treatment compliance in individuals with chronic diseases.
  • To assess short-term and long-term changes in medication adherence post-Hajj.
  • To explore the relationship between religiousness and disease management during this pilgrimage.

Main Methods:

  • Prospective and descriptive study design.
  • Inclusion of 168 individuals with chronic diseases.
  • Data collection via three interviews using patient identification and Religiousness Inclination Scale.

Main Results:

  • A statistically significant short-term decrease in regular medicine use was observed after Hajj (p=0.011).
  • No significant difference in treatment compliance was found at the 3-month follow-up (p=0.094).
  • No correlation was found between internally driven religiousness and changes in disease complaints or coping mechanisms post-Hajj.

Conclusions:

  • Hajj pilgrimage can negatively affect treatment compliance in the short term for patients with chronic conditions.
  • Long-term treatment compliance is not significantly altered by the Hajj pilgrimage.
  • Religious inclination does not appear to mediate the relationship between Hajj and disease management outcomes in the short term.

Keywords:
Chronic diseaseHajjReligiousSpiritualiteTreatment compliance

More Related Videos

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.6K
Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding02:41

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding

Published on: May 3, 2024

2.3K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
976
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K